Across RP genes, the frequency of mutations in or deletions of RPL5 is relatively high, with several reported cases in breast cancer, multiple myeloma (MM), melanoma, glioblastoma, and T-cell acute lymphoblastic leukemia (T-ALL) [95,116,120,121]. The gene discussed is RPL5; the disease is Miyoshi myopathy.